Charcot-Marie-Tooth disease with pyramidal features due to a new mutation of EGR2 gene.

Charcot-Marie-Tooth disease with pyramidal features due to a new mutation of EGR2 gene.

Authors

  • Carlo Fusco Department of Pediatrics, Child Neurology Unit, Santa Maria Nuova Hospital, IRCCS, viale Risorgimento 80, 42123 Reggio Emilia, Italy. Department of Pediatrics, Pediatric Neurophysiology Laboratory, Santa Maria Nuova Hospital, IRCCS, viale Risorgimento 80, 42123 Reggio Emilia, Italy.
  • Carlotta Spagnoli Department of Pediatrics, Child Neurology Unit, Santa Maria Nuova Hospital, IRCCS, viale Risorgimento 80, 42123 Reggio Emilia, Italy.
  • Grazia Gabriella Salerno Department of Pediatrics, Child Neurology Unit, Santa Maria Nuova Hospital, IRCCS, viale Risorgimento 80, 42123 Reggio Emilia, Italy.
  • Elena Pavlidis Department of Pediatrics, Child Neurology Unit, Santa Maria Nuova Hospital, IRCCS, viale Risorgimento 80, 42123 Reggio Emilia, Italy.
  • Daniele Frattini Department of Pediatrics, Child Neurology Unit, Santa Maria Nuova Hospital, IRCCS, viale Risorgimento 80, 42123 Reggio Emilia, Italy.
  • Francesco Pisani Child Neuropsychiatry Unit, Medicine & Surgery Department, University of Parma, Italy.
  • Maria Teresa Bassi Laboratory of Molecular Biology, Scientific Institute IRCCS E. Medea, Via. d.L. Monza 20, 23842 Bosisio Parini, Lecco.

Keywords:

EGR2, Charcot-Marie-Tooth, CMT-1D, hereditary polyneuropathy, pediatric, sensory-motor neuropathy

Abstract

Background and aim of the work: Childhood-onset peripheral neuropathies are often of genetic origin. Charcot-Marie-Tooth (CMT), is considered the commonest neuromuscular disorder. Due to its high clinical heterogeneity, especially in the pediatric age, the co-existence of central and peripheral symptoms and signs does not necessarily rule out a diagnosis of hereditary peripheral neuropathy. Methods: We describe the clinical, neurophysiological and genetic findings in a teen-age patient evaluated for acquired toe-walking and progressive difficulties in walking since the age of 5. Genetic testing was carried out with a targeted NGS panel. Identified variants are analyzed using Variant Studio program (Illumina). Rare variants and variants considered as pathogenic were analyzed by Sanger direct sequencing. Results: The coexistence of peripheral and pyramidal signs in the lower limbs, the absence of a significant pre/perinatal history, the unremarkable brain and spine MRI, together with the presence of a sensory-motor polyneuropathy in all four limbs, prompted the execution of genetic investigations with an NGS panel covering hereditary spastic paraplegias, motor neuron disease and Charcot-Marie-Tooth. We identified a previously undescribed variant (c.1142G>T, p.Arg381Leu) in the EGR2 gene. Conclusions: ERG2 gene has been described as a cause of various phenotypes, including a rare autosomal dominant form of CMT (CMT type 1D) representing approximately 1% of all CMT subgroups. We describe a novel pathogenic variant in EGR2 gene leading to the development of a complex association of peripheral and central neurological signs, underscoring the genetic and clinical heterogeneity of hereditary neuropathies of pediatric onset.

Author Biography

Carlo Fusco, Department of Pediatrics, Child Neurology Unit, Santa Maria Nuova Hospital, IRCCS, viale Risorgimento 80, 42123 Reggio Emilia, Italy. Department of Pediatrics, Pediatric Neurophysiology Laboratory, Santa Maria Nuova Hospital, IRCCS, viale Risorgimento 80, 42123 Reggio Emilia, Italy.

Head of the Unit

Department of Pediatrics, Child Neurology Unit, Santa Maria Nuova Hospital, IRCCS, viale Risorgimento 80, 42123 Reggio Emilia, Italy.

Department of Pediatrics, Pediatric Neurophysiology Laboratory, Santa Maria Nuova Hospital, IRCCS, viale Risorgimento 80, 42123 Reggio Emilia, Italy.

Downloads

Published

24-01-2019

Issue

Section

CASE REPORTS

How to Cite

1.
Fusco C, Spagnoli C, Salerno GG, Pavlidis E, Frattini D, Pisani F, et al. Charcot-Marie-Tooth disease with pyramidal features due to a new mutation of EGR2 gene. Acta Biomed [Internet]. 2019 Jan. 24 [cited 2024 Jul. 23];90(1):104-7. Available from: https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/6951